Identifying genetic factors that affect survival in prostate cancer patients
Genetic Predictors of Prostate Cancer Survival
This study is looking at how certain genes can help doctors understand which men with prostate cancer might have a tougher time fighting the disease, so they can offer more tailored treatments and better screening options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11058430 on NIH RePORTER |
What this research studies
This research investigates how specific genetic markers can predict survival outcomes for men diagnosed with prostate cancer. By analyzing a combination of a four-kallikrein biomarker panel and genetic variations, the study aims to improve the accuracy of identifying which patients are at higher risk of dying from the disease. The approach utilizes advanced genomic analysis techniques to explore how genetic changes influence survival times. This could lead to more personalized treatment strategies and better screening methods for prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are American men diagnosed with prostate cancer who are seeking more personalized treatment options.
Not a fit: Patients with prostate cancer who are not interested in genetic testing or those with very early-stage disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved screening and treatment strategies that better target men at risk of dying from prostate cancer.
How similar studies have performed: Previous research has shown promise in using genetic markers to predict cancer outcomes, suggesting that this approach could yield significant insights.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Klein, Robert J. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Klein, Robert J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.